OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Discovery and biological evaluation of 4,6-pyrimidine analogues with potential anticancer agents as novel colchicine binding site inhibitors
Jifa Zhang, Lun Tan, Chengyong Wu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 248, pp. 115085-115085
Closed Access | Times Cited: 7
Jifa Zhang, Lun Tan, Chengyong Wu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 248, pp. 115085-115085
Closed Access | Times Cited: 7
Showing 7 citing articles:
Recent Advances in Pyrimidine-Based Drugs
Baskar Nammalwar, Richard A. Bunce
Pharmaceuticals (2024) Vol. 17, Iss. 1, pp. 104-104
Open Access | Times Cited: 40
Baskar Nammalwar, Richard A. Bunce
Pharmaceuticals (2024) Vol. 17, Iss. 1, pp. 104-104
Open Access | Times Cited: 40
Evaluation of apoptosis in human breast cancer cell (MDA-MB-231) induced by ZnO nanoparticles synthesized using Piper betle leaf extract as bio-fuel
Shobha Nagarajaiah, N. Nanda, M. Praveen, et al.
Applied Physics A (2023) Vol. 129, Iss. 6
Closed Access | Times Cited: 8
Shobha Nagarajaiah, N. Nanda, M. Praveen, et al.
Applied Physics A (2023) Vol. 129, Iss. 6
Closed Access | Times Cited: 8
Discovery and mechanistic insights into thieno[3,2-d]pyrimidine and heterocyclic fused pyrimidines inhibitors targeting tubulin for cancer therapy
Chengyong Wu, Lele Zhang, Zhilan Zhou, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116649-116649
Closed Access | Times Cited: 2
Chengyong Wu, Lele Zhang, Zhilan Zhou, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116649-116649
Closed Access | Times Cited: 2
Design, synthesis, and biological evaluation of 4-aryl-9H-carbazoles as tubulin polymerization inhibitors with potent anticancer activities
Chao Wang, Yujing Zhang, Shanbo Yang, et al.
Arabian Journal of Chemistry (2023) Vol. 16, Iss. 10, pp. 105146-105146
Open Access | Times Cited: 4
Chao Wang, Yujing Zhang, Shanbo Yang, et al.
Arabian Journal of Chemistry (2023) Vol. 16, Iss. 10, pp. 105146-105146
Open Access | Times Cited: 4
Structure-based approaches for the design of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d][1,2,3]triazoles as tubulin polymerization inhibitors
Mingxin Huang, Hongyao Han, H.C. Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116309-116309
Closed Access | Times Cited: 1
Mingxin Huang, Hongyao Han, H.C. Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116309-116309
Closed Access | Times Cited: 1
Combretastatin A-4 based compounds as potential anticancer agents: A review
Moien A. Omar, Soha H. Emam, Demiana S. Mikhail, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107930-107930
Closed Access | Times Cited: 1
Moien A. Omar, Soha H. Emam, Demiana S. Mikhail, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107930-107930
Closed Access | Times Cited: 1
Discovery and Mechanistic Insights into Thieno[3,2-D]Pyrimidine and Heterocyclic Fused Pyrimidines Inhibitors Targeting Tubulin for Cancer Therapy
Yuxi Wang, Chengyong Wu, Lele Zhang, et al.
(2024)
Closed Access
Yuxi Wang, Chengyong Wu, Lele Zhang, et al.
(2024)
Closed Access
